Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 4, 2016

Garlic capsule and selenium-vitamins ACE combination therapy modulate key antioxidant proteins and cellular adenosine triphosphate in lisinopril-induced lung damage in rats

  • Jacob K. Akintunde EMAIL logo , Olakunle Enock Bolarin and Daniel G. Akintunde

Abstract

Background: Garlic capsule (GAR) and/or selenium- vitamin A, C, E (S-VACE) might be useful in the treatment of lung diseases. The present study evaluated the toxicity of lisinopril (LIS) in the lungs of male rats and the reversal effect of GAR and/or selenium-vitamins A, C, and E (S-VACE).

Methods: Group I served as the control, whereas animals in groups II, III, IV, and V received 28 mg of LIS/kg body weight by gavage. Group III was co-treated with GAR at a therapeutic dosage of 250 mg/kg body weight per day. Group IV was co-treated with S-VACE at dosage of 500 mg/kg body weight per day. Lastly, group V was co-treated with GAR and S-VACE at dosages of 250 and 500 mg/kg body weight per day, respectively. The experiment lasted for 8 days (sub-acute exposure).

Results: Administration of therapeutic dose of LIS to male rats depleted enzymatic antioxidants (superoxide dismutase and catalase) and cellular adenosine triphosphate content with concomitant increase in lipid peroxidation. Histopathology examination showed damage to the epithelial cells of the airways. These effects were prevented by both single and combination treatment of GAR and S-VACE in male rats with LIS-induced lung toxicity.

Conclusions: We therefore concluded that the combination of GAR and S-VACE can be a novel therapy for the management of lung diseases in humans.


Corresponding author: Jacob K. Akintunde, Toxicology Unit, Department of Environmental Health Sciences, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Nigeria, Fax: +23408064156056, E-mail: ; and Biochemistry Unit, Department of Bioscience and Biotechnology, College of Pure and Applied Sciences, Kwara State University, Malete, Nigeria

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ramalho FS, Ramalho LN, Castro-e-Silva Junior O, Zucoloto S, Correa FM. Angiotensin-converting enzyme inhibitor by lisinopril enhances liver regeneration in rats. Braz J Med Biol Res 2001;34:125–7.10.1590/S0100-879X2001000100016Search in Google Scholar

2. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS study group. Circulation 1999;100:2312–8.10.1161/01.CIR.100.23.2312Search in Google Scholar

3. Weber KT, Brilla CG, Janicki JS. Cardioreparation with lisinopril in the management of hypertension and heart failure. Cardiology 1991;791:62–73.10.1159/000174908Search in Google Scholar

4. Sevak AR, Goyal RK. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats. Pharmacol Res 1996;34:201–9.10.1006/phrs.1996.0089Search in Google Scholar

5. Snively CS, Gutierrez C. Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 2004;70:1921–8.Search in Google Scholar

6. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2030. Diabetes Res Clin Pract 2010;87:4–14.10.1016/j.diabres.2009.10.007Search in Google Scholar

7. Michael RS. Role for automated communication strategies in medication adherence management. Am Health Drug Benefit 2008;1:20–7.Search in Google Scholar

8. Karabuga L, Akbay K, Turna B, Vatansever HS, Altay B, Guzel E, et al. Effect of lisinopril on renal tissue damage in unilateral ureteral obstruction in rats. Urol Res 2012;40:27–34.10.1007/s00240-011-0393-7Search in Google Scholar

9. Tuncdemir M, Ozturk M. The effects of ACE inhibitor and angiotensin receptor blocker on clusterin and apoptosis in the kidney tissue of streptozotocin-diabetic rats. J Mol Histol 2008;39:605–16.10.1007/s10735-008-9201-2Search in Google Scholar

10. Radovic N, Cuzic S, Knotek M. Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule and interstitial cell apoptosis in rats. Croat Med J 2008;49:600–7.10.3325/cmj.2008.5.600Search in Google Scholar

11. Valenzuenla C, Perez O, Delpon E, Tamarqo J. Effects of lisinopril on cardiac contractility and ionic currents. Gen Pharmacol 1994;25:825–32.10.1016/0306-3623(94)90083-3Search in Google Scholar

12. Kratnov AE, Popov SA, Kratnov AA. Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2. Ter Arkh 2005;77:14–8.Search in Google Scholar

13. Jane M. Lisinopril associated with many serious side effects, including angioedema, liver damage. Legal News Articles – Drugs/Medical. Washington DC, 2011; Aug 31–11.Search in Google Scholar

14. Oktem F, Kirbas A, Armagan A, Kuybulu AE,Yilmaz HR, Ozoquner F, Uz E. Lisinopril attenuates renal oxidative injury in L-NAME-induced hypertensive rats. Mol Cell Biochem 2011;352:247–53.10.1007/s11010-011-0760-2Search in Google Scholar PubMed

15. Mastan RY, Aparna LI, Saroja M. Effect of ACE inhibitors an antioxidant status in stroptozocin induced diabetic rats. Asian J Pharm Clin Res 2011;4:134–7.Search in Google Scholar

16. Osama AH, Fadhel AA. Comparative study of lisinopril versus telmisartan effects on oxidative stress in diabetic type 2 hypertensive patients. Raf J Sci 2012;23:34–41.10.33899/rjs.2012.44367Search in Google Scholar

17. Velayutham PK, Adhikary SD, Babu SK, Vedantam R, Korula G, Ramachandra A. Oxidative stress-associated hypertension in surgically induced brain injury patients: effects of β-blocker and angiotensin-converting enzyme inhibitor. J Surg Res 2013;179:125–31.10.1016/j.jss.2012.09.005Search in Google Scholar

18. Chandran G, Sirajudeen KN, Nik S, Nik Y, Swamy M, Mutum SS. Effect of the antihypertensive drug enalapril on oxidative stress markers and antioxidant enzymes in kidney of spontaneously hypertensive rat. Oxid Med Cell Longevity 2014;2014:608512.10.1155/2014/608512Search in Google Scholar

19. Ugusman A, Zakaria Z, Kien Hui C, Megat NA, Mohd N. Piper sarmentosum inhibits ICAM-1 and Nox4 gene expression in oxidative stress-induced human umbilical vein endothelial cells. BMC Complement Altern Med 2011;11:1062–9.10.1186/1472-6882-11-31Search in Google Scholar

20. Duarte TL, Lunec J. When is an oxidant not an antioxidant? A review novel actions and reactions of vitamin C. Free Radic Res 2005;39:671–86.10.1080/10715760500104025Search in Google Scholar

21. Borek C. Garlic reduces dementia and heart disease risk. J Nutr 2006;1363:810–2.10.1093/jn/136.3.810SSearch in Google Scholar

22. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 2007;104:17977–82.10.1073/pnas.0705710104Search in Google Scholar

23. Davis CD. Selenium supplementation and cancer prevention. Curr Nutr Rep 2012;1:16–23.10.1007/s13668-011-0003-xSearch in Google Scholar

24. Rayman NP. Selenium and human health. Lancet 2012;379:1256–68.10.1016/S0140-6736(11)61452-9Search in Google Scholar

25. Reid ME, Duffied-Lillico AJ, Sunga A. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer 2006;118:1777–81.10.1002/ijc.21529Search in Google Scholar PubMed

26. Kosenko EA, Suslikov AV, Venediktova NI, Kaminsky YG. Erythrocyte antioxidant enzymes in hypertensive patients receiving lisinopril monotherapy or combined lisinopril plus simvastatin therapy. Biochem (Moscow) 2011;4(Suppl B):395–99.10.1134/S1990750810040128Search in Google Scholar

27. Bodnar M, Konieczka P, Namiesnik J. The properties, functions, and use of selenium compounds in living organisms. J Environ Sci Health C 2012;30:225–52.10.1080/10590501.2012.705164Search in Google Scholar

28. Halliwell B, Gutteridge JM, Arouma OI. The deoxyribose method: simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 1997;165:215–9.10.1016/0003-2697(87)90222-3Search in Google Scholar

29. Public Health Service (PHS). Public health service policy on humane care and use of laboratory animals. Health Research Extension Act 1985 (PL 99-58). Washington, DC: US Department of Health and Human Services, 1996.Search in Google Scholar

30. Clairborne A. Catalase activity. In: Greewald AR, editor. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press, 1995:237–42.Search in Google Scholar

31. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay of superoxide dismutase. Toxicol Biol Chem 1989;2417:3170.10.1016/S0021-9258(19)45228-9Search in Google Scholar

32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8.10.1016/0003-2697(79)90738-3Search in Google Scholar

33. Weisshaar HD. Estimation of lactate dehydrogenase in serum/plasma. Med Welt 1975;26:387.Search in Google Scholar

34. Zar JH. Biostatistical analysis. Prentice-Hall, USA, 1984:620.Search in Google Scholar

35. Andreadis AA, Hazen SL, Comhair SA, Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 2003;35:213–25.10.1016/S0891-5849(03)00278-8Search in Google Scholar

36. Cho H, Diamond MS. Immune responses to West Nile virus infection in the central nervous system. Viruses 2012;4:3812–30.10.3390/v4123812Search in Google Scholar

37. Beuermann S, Buback M, Isemer C, Wahl A. Homogeneous free-radical polymerization of styrene in supercritical CO2. Macromol Rapid Commun 1999;20:26–32.10.1002/(SICI)1521-3927(19990101)20:1<26::AID-MARC26>3.0.CO;2-2Search in Google Scholar

38. Fang YZ, Fang YZ, Zheng RL. Free radicals and nutrition. Theory and application of free radical biology. Beijing: Scientific Press, 1999:647.Search in Google Scholar

39. Farombi EO, Shrotriya S, Surh Y. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci 2009;84:149–55.10.1016/j.lfs.2008.11.012Search in Google Scholar

40. Guoyao W, Yun-Zhong F, Sheng Y, Joanne R, Nancy D. Glutathione metabolism and its implications for health. J Nutr 2004;134:489–92.10.1093/jn/134.3.489Search in Google Scholar

41. Van Winkle LS, Fanucchi MV, Malburg SR, Nishio SJ, Chang A, Buckpitt AR. Early events in naphthalene-induced acute Clara cell toxicity. II. Comparison of glutathione depletion and histopathology by airway location. Am J Respir Cell Mol Biol 2001;24:272–81.10.1165/ajrcmb.24.3.4247Search in Google Scholar

42. Bech KM, Beier J, Koppenhoefer N, Buhl R. Increased glutathione disulfide and nitrosothiols in sputum of patients with stable COPD. Chest 2004;126:1116–22.10.1378/chest.126.4.1116Search in Google Scholar PubMed

43. Cruzan G, Bus J, Banton M, Gingell R, Carlson G. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action. Regul Toxicol Pharmacol 2009;55:205–18.10.1016/j.yrtph.2009.07.002Search in Google Scholar PubMed

44. Sutherland KM, Edwards PC, Combs TJ, Van Winkle LS. Sex differences in the development of airway epithelial tolerance to naphthalene. Am J Physiol Lung Cell Mol Physiol 2012;302:68–81.10.1152/ajplung.00089.2011Search in Google Scholar PubMed PubMed Central

45. Paul K, Irfan R. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476–94.10.1016/j.pharmthera.2005.10.015Search in Google Scholar PubMed

46. Saghir SA, Zhang F, Rick DL, Kan L, Bus JS, Bartels MJ. In vitro metabolism and covalent binding of ethylbenzene to microsomal protein as a possible mechanism of ethylbenzene-induced mouse lung tumorigenesis. Regul Toxicol Pharmacol 2010;57:129–35.10.1016/j.yrtph.2010.01.003Search in Google Scholar PubMed

47. Cruzan G, Bus J, Hotchkiss J, Sura R, Moore C, Yost G, et al. Studies of styrene, styrene oxide and 4-hydroxystyrene toxicity in CYP2F2 knockout and CYP2F1 humanized mice support lack of human relevance for mouse lung tumors. Regul Toxicol Pharmacol 2013;66:2439.10.1016/j.yrtph.2013.02.008Search in Google Scholar PubMed

48. Comhair SA, Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 2010;12:93–124.10.1089/ars.2008.2425Search in Google Scholar PubMed PubMed Central

49. Fransen M, Nordgren M, Wang B, Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim Biophys Acta 2012;1822:1363–73.10.1016/j.bbadis.2011.12.001Search in Google Scholar PubMed

50. Awodele O, Akintonwa A, Osunkalu V, Coker HA. Modulatory activity of antioxidants against the toxicity of rifampicin in vivo. Rev Inst Med Trop de Sao Paulo 2010;52:43–6.10.1590/S0036-46652010000100007Search in Google Scholar PubMed

51. Akintunde JK, Oboh G, Akindahunsi AA. Inhibition of key markers linked with spermatogenesis and cellular ATP by subchronic exposure to leachate in a rat model. Arch Environ Contam Toxicol 2015;68:159–68.10.1007/s00244-014-0068-9Search in Google Scholar PubMed

52. Akintunde JK, Oboh G. Depletion of cellular adenosine triphosphate and hepatocellular damage in rat after sub-chronic exposure to leachate from antropogenic recycling site. Hum Exp Toxicol 2015;34:1083–95.10.1177/0960327115569809Search in Google Scholar PubMed

53. Mc Clenahan D, Hillenbrand K, Kapur A, Carlton D, Czuprynski C. Effects of extracellular ATP on bovine lung endothelial and epithelial cell monolayer morphologies, apoptoses, and permeabilities. Clin Vaccine Immunol 2008;16:43–8.10.1128/CVI.00282-08Search in Google Scholar PubMed PubMed Central

54. Ferrari D, Di Virgilio F, Virchow JC, Zissel G, Boeynaems J-M. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J Immunol 2010;185:688–97.10.4049/jimmunol.0904042Search in Google Scholar PubMed

55. Vanderstocken G, Van de Paar E, Robaye B, Pietrantonio L, Bondue B, Boeynaems JM, et al. Protective role of P2Y2 receptor against lung infection induced by pneumonia virus of mice. PLoS One 2012;7:e50385.10.1371/journal.pone.0050385Search in Google Scholar PubMed PubMed Central

56. Agrawal DK, Shao Z. Pathogenesis of allergic airway inflammation. Curr Allergy Asthma Rep 2010;10:39–48.10.1007/s11882-009-0081-7Search in Google Scholar PubMed PubMed Central

57. McGee HS, Stallworth AL, Agrawal T, Shao Z, Lorence L, Agrawal DK. Fms-like tyrosine kinase 3 ligand decreases T helper type17 cells and suppressors of cytokine signalling proteins in the lung of house dust mite-sensitized and -challenged mice. Am J Respir Cell Mol Biol 2010;43:520–9.10.1165/rcmb.2009-0241OCSearch in Google Scholar PubMed PubMed Central

58. Besnard A-G, Togbe D, Couillin I, Tan Z, Zheng SG. Inflammasome-IL-1-Th17 response in allergic lung inflammation. J Mol Cell Biol 2012;4:3–10.10.1093/jmcb/mjr042Search in Google Scholar PubMed

59. Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in COPD: where do we stand? Mediat Inflamm 2013;2013:413735.10.1155/2013/413735Search in Google Scholar PubMed PubMed Central

Received: 2015-9-16
Accepted: 2016-1-26
Published Online: 2016-3-4
Published in Print: 2016-3-1

©2016 by De Gruyter

Downloaded on 29.2.2024 from https://www.degruyter.com/document/doi/10.1515/dmpt-2015-0035/html
Scroll to top button